Guangdong, China

Wei Yang

This inventor holds 10 USPTO granted patents and 4 published patent applications. Top assignees: Guangdong Cs-Lewwin Drug Research Co., Ltd., Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd., Guangdong Epropulsion Technology Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Yang. Retrieved from https://idiyas.com/inventor/wei-yang-r11yujn7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Wei Yang

Introduction

Wei Yang is a prominent inventor based in Guangdong, China, known for his significant contributions to the field of pharmaceuticals and microfluidic technology. With a total of nine patents to his name, he has made remarkable advancements that have the potential to impact medical research and treatment.

Latest Patents

One of Wei Yang's latest patents is a microfluidic device for digital droplet PCR. This innovative device includes a main body, a sealing layer, and multiple Polymerase Chain Reaction (PCR) units arranged on the main body. Each PCR unit features a microchannel on the surface of the main body, along with a sample reservoir, an oil reservoir, a droplet generation zone, a transition zone, a droplet storage zone, and a collection zone that are interconnected through the microchannel. The sealing layer is designed to cover the main body, ensuring that the generated droplets are collected in the oil reservoir and subsequently distributed to the droplet storage zone via the transition zone.

Another notable patent is related to a pyrimidine derivative and its preparation process for treating tumors. This invention demonstrates anti-tumor activity at the cellular level, particularly in tumor cells expressing c-Met. The method involves introducing a chiral structure into the molecule, incorporating an isotope of hydrogen (deuterium) at metabolically vulnerable sites, and adding atoms or groups such as sulfur, selenium, and sulfoxide. These modifications result in compounds with excellent anti-tumor activities and improved stability.

Career Highlights

Wei Yang has worked with several reputable organizations, including the Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. and Guangdong Cs-Lewwin Drug Research Co., Ltd. His work in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in drug research and development.

Collaborations

Wei Yang has collaborated with notable colleagues, including Xingshu Li and Xinzi Chen. Their combined expertise has fostered a productive environment for innovation and research.

Conclusion

Wei Yang's contributions to the fields of microfluidics and pharmaceuticals highlight his role as a leading inventor. His innovative patents and collaborative efforts continue to pave the way for advancements in medical technology and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…